Doing an excellent job is not just the clinical trials. It’s running the company as a business, being financially astute and preserving shareholder value and the market cap of the company.
listen to her recent speeches, she is disappointed that the share price is where it is?
Why wasn’t the disappointed there when it was at 8c.
the other red flag you should note is she feels the value should be about a billion dollars. No where near your 15c target, courtesy of significant dilution.
A $2m a year CEO would not let this destruction occur. You can blame the market to an extent, but at some point you need to look in the mirror and ask, am I in over my head? Should I be in a role leading one of the trials? It’s clear she’s incapable, because Hopper is directing the ship.
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)